Trials / Completed
CompletedNCT01379651
Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy
Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ospedale Buon Consiglio Fatebenefratelli · Academic / Other
- Sex
- All
- Age
- 5 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.
Detailed description
Oral immunotherapy consisted in the administration of increasing amounts of raw emulsion egg. The children started with 1 drop of undiluted raw egg emulsion (0.05 ml) flavored with vanilla and cacao, hidden by the parents in the child's breakfast (cow's milk, soymilk, fruit juice or other). The dose was doubled at intervals of about one month in the day hospital. The increases in dose were customized for each subject based on the frequency and severity of side effects, or when an inter-current illness or asthma worsening intervened during the SOTI. The investigators limited the SOTI protocol to six months for all patients, irrespective of the dose reached, in order to favor the adherence of families to the study. When objective symptoms seemed more important (grade 2, 3 and 4 reaction), medical treatment was given. Subjects were discontinued from the study in case of severe adverse reactions (grade 5 reaction). Parents were advised they could telephone investigators 24 hours a day
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Specific oral tolerance induction | Specific oral tolerance induction consisted in the administration of increasing amounts of raw emulsion egg |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2011-06-23
- Last updated
- 2011-09-20
- Results posted
- 2011-08-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01379651. Inclusion in this directory is not an endorsement.